In Non-Small Cell Lung Cancer Patients, TEMLA Shows Higher Diagnostic Yield Than EBUS Or EUS In Largest Reported Series To Date, International Association for the Study of Lung Cancer (IASLC) Reveals

In the largest reported series yet to compare transcervical extended mediastinal lymphadenectomy (TEMLA) with endoscopic and surgical primary staging and restaging of non-small cell lung cancer (NSCLC), TEMLA showed a significantly higher diagnostic yield, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).

MORE ON THIS TOPIC